FINWIRES · TerminalLIVE
FINWIRES

Aecon Group Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$44.50

By

-- Stifel Canada on Wednesday reiterated its hold rating on the shares of Aecon Group (ARE.TO) and its C$44.50 price target following the engineering and construction company's first-quarter results.

"In 1Q26, Aecon delivered a 10.9% revenue beat and 19.7% EBITDA beat relative to consensus, but we are categorizing it as a neutral quarter. 1Q26 only accounts for ~9% of full year EBITDA (thus the absolute beat is only a modest positive) and the full year outlook remains unchanged. Additionally, the stock has increased 53.8% YTD (S&P/TSX: +5.9%) and the valuation is full at 25.2x 2027E P/E (10Y avg: 14.6x, N.A. peer group average: 22.5x). Valuation remains the basis for our HOLD rating and that view is unchanged, but we believe the company remains well positioned to benefit from Canadian government spending on nuclear, defense work and infrastructure," analyst Ian Gillies wrote.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Australia

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Research

Research Alert: Columbia Sportswear Company Beats Estimates; Raises Full-year Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:COLM posted Q1 2026 EPS of $0.65 vs. $0.75 prior year, $0.30 above consensus on flat net sales of $779M, $21M above estimates. International diversification proved valuable with EMEA surging 35% and LAAP growing 5%, offsetting a 10% U.S. decline, while gross margin contracted 20 bps to 50.7% primarily from a 310-bp incremental tariff impact. We believe the international growth strategy is effectively insulating the company from U.S. tariff headwinds and positioning it for sustained global expansion. Management raised full-year EPS guidance to $3.55-$4.00 from prior $3.20-$3.65 and operating margin guidance to 6.7%-7.5% reflecting better tariff conditions. The company maintains its fortress balance sheet with $535.4M cash and no debt while executing a $150M share repurchase program. We are impressed with international performance driving growth and expect continued momentum from the ACCELERATE Growth Strategy targeting younger consumers, with shares trading at 17x forward EPS guidance.

$COLM
Mining & Metals

Fairfax India Holdings Corp Announcing FY25 Net Earnings of US$410.5M or $3.05 Net Earnings Per Diluted Share

$FIH-U.TO